Potential participants will be screened for inclusion in the study. You will then be enrolled and asked to attend the study site, fill out questionnaires, have a finger prick test, undertake a body composition assessment and be allocated to the treatment group or placebo.
Following this you will undertake a blood test and be asked to take the allocated product daily for 6 months and to attend the study site every 2 months for an assessment. Each assessment will involve filling out questionnaires, undertaking a progress interview and having a finger prick test. You are also required to undertake a blood test at months 2 and 4.
At the end of the study, you will also be asked to attend the study site to complete questionnaires, body composition assessment, exit interview and you will be asked to have a final blood test.